
Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc.(BDTX)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
bdtx · 股价预测 · 11 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$8.00
Consensus
$8.00
+332.4% upside
Low
$8.00
Median: $8 · Last Close: $1.85
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.76 | ↓ 5.00% |
1-day model range: $1.73–$1.79. Peak: $1.79 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -47.0% |
| 2028 | $1 | -59.5% |
| 2029 | $1 | -64.2% |
| 2030 | $1 | -66.3% |
| 2031 | — | -67.3% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BDTX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-29 | BTIG | Maintains | Buy→Buy |
| 2026-03-17 | Wedbush | Maintains | Outperform→Outperform |
| 2026-01-16 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-12-04 | Guggenheim | Downgrade ↓ | Buy→Neutral |
| 2025-08-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-07 | Stifel | Maintains | Buy→Buy |
| 2024-11-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-10-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-10-08 | Wedbush | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Black Diamond Therapeutics, Inc. (BDTX) stock. Of the recent 40 rating actions, 3 were upgrades and 3 were downgrades. 11 analysts currently cover BDTX.
分析师推荐趋势
BDTX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$7M
↓ 38.4% YoY
Revenue Next Year
$3M
↓ 60.2% YoY
EPS This Year
$-0.65
EPS Next Year
$-1.00
↑ 55.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast BDTX EPS of $-0.65 for the current fiscal year, based on estimates from 7 analysts. The BDTX revenue forecast is $7M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
BDTX 股价预测由两类独立数据源支撑:来自 11 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。BDTX 的共识目标价为 $8.00(+332.4% 上行空间),分析师共识为 Buy。
BDTX 的短期预测(明日)为 $1.76(-5.00%)。 BDTX 对 2027 年的股价预测均值为 $1。 BDTX 对 2030 年的预测区间为 $1–$1。
Black Diamond Therapeutics, Inc. 在 NASDAQ 上市,代码 BDTX。BDTX 在 2027 年的整体展望偏积极,在覆盖分析师中约 91% 对应 Buy 共识。
常见问题
BDTX 预测 · 8 个问题根据 11 位华尔街分析师,BDTX 的 12 个月平均目标价为 $8.00,最高 $8.00、最低 $8.00。若有图表,中位目标价可在上方查看。相对当前价 $1.85,隐含约 +332.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.